Stephan Riedmaier
Impact in
- Pharmacology top 5%
- Pharmacogenetics and Drug Metabolism
- Drug-Induced Hepatotoxicity and Protection
-
- Paraoxonase enzyme and polymorphisms
Papers in
-
- Pharmacogenetics and Drug Metabolism 4
-
- Mitochondrial Function and Pathology 2
- Coenzyme Q10 studies and effects 1
- Ion Transport and Channel Regulation 1
- Co-authors
- Ulrich M. Zanger (5 shared papers)Ute Hofmann (3 shared papers)Kathrin Klein (3 shared papers)Matthias Schwab (3 shared papers)Mikko Niemi (1 shared paper)Jenni E. Keskitalo (1 shared paper)Pertti J. Neuvonen (1 shared paper)Wolfgang E. Thasler (2 shared papers)
- Journals
- Free Radical Biology and Medicine (2 papers)BMC Systems Biology (1 paper)Clinical Therapeutics (1 paper)Drug Metabolism and Disposition (1 paper)Journal of Proteome Research (1 paper)
- Partner nations
- GermanyUnited StatesFinland
In The Last Decade
Stephan Riedmaier
8 papers receiving 314 citations
Peers
Comparison fields: 5 of 60
- Pharmacology 120
- Clinical Biochemistry 29
- Oncology 77
- Biochemistry 19
- Endocrinology, Diabetes and Metabolism 35
Countries citing papers authored by Stephan Riedmaier
This map shows the geographic impact of Stephan Riedmaier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephan Riedmaier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephan Riedmaier more than expected).
Fields of papers citing papers by Stephan Riedmaier
This network shows the impact of papers produced by Stephan Riedmaier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephan Riedmaier. The network helps show where Stephan Riedmaier may publish in the future.
Co-authors
The 25 scholars most cited alongside Stephan Riedmaier, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 86 | |
| 2 | 2010 | 78 | |
| 3 | 2008 | 55 | |
| 4 | 2011 | 42 | |
| 5 | 2014 | 27 | |
| 6 | 2011 | 16 | |
| 7 | 2021 | 13 | |
| 8 | 2023 | 8 |
About Stephan Riedmaier
Stephan Riedmaier is a scholar working on Pharmacology, Molecular Biology, Oncology, Clinical Biochemistry and Endocrinology, Diabetes and Metabolism, having authored 8 papers that have together received 325 indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (4 papers), Mitochondrial Function and Pathology (2 papers), Drug Transport and Resistance Mechanisms (2 papers), Coenzyme Q10 studies and effects (1 paper), Advanced Proteomics Techniques and Applications (1 paper), Analytical Chemistry and Chromatography (1 paper), Adipose Tissue and Metabolism (1 paper) and Ion Transport and Channel Regulation (1 paper). The work is most often cited by research in Pharmacology (120 citations), Clinical Biochemistry (29 citations), Oncology (77 citations), Biochemistry (19 citations) and Endocrinology, Diabetes and Metabolism (35 citations). Stephan Riedmaier has collaborated with scholars based in Germany, United States and Finland. Frequent co-authors include Ulrich M. Zanger, Ute Hofmann, Kathrin Klein, Matthias Schwab, Mikko Niemi, Jenni E. Keskitalo, Pertti J. Neuvonen, Wolfgang E. Thasler, Thomas S. Weiß and Daniel Knobeloch. Their work appears in journals such as Free Radical Biology and Medicine, BMC Systems Biology, Clinical Therapeutics, Drug Metabolism and Disposition and Journal of Proteome Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.